Global gene expression in a type 2 Gaucher disease brain

Molecular Genetics and Metabolism

Volumn 83, Issue 4, 2004, Pages 288-296

  Myerowitz, Rachel ^a,b   Mizukami, Hiroki ^b   Richardson, Kristine L ^a   Finn, Laura S ^c   Tifft, Cynthia J ^b,d   Proia, Richard L ^b  

^a ST MARY'S COLLEGE OF MARYLAND   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Gaucher disease; Gene expression profiling; Lysosomal storage disease; Sphingolipidoses

Indexed keywords

GAMMA SYNUCLEIN;

ARTICLE; CONTROLLED STUDY; GAUCHER DISEASE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; NERVE DEGENERATION; PRIORITY JOURNAL; SANDHOFF DISEASE; SERIAL ANALYSIS OF GENE EXPRESSION; STORAGE DISEASE; TAY SACHS DISEASE;

SALVIA;

EID: 13844316299     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2004.06.020     Document Type: Article

References (40)

1. R.O. Brady, J.N. Kanfer, and D. Shapiro Metabolism of Glucocerebrosides. Evidence of an Enzymatic Deficiency in Gaucher's Disease Biochem. Biophys. Res. Commun. 18 1965 221 225
2. E. Beutler, and G.A. Grabowski Gaucher disease eighth ed. C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The Metabolic and Molecular Basis of Inherited Disease vol. III 2001 McGraw-Hill New York 3635 3668
3. E. Sidransky New perspectives in type 2 Gaucher disease Adv. Pediatr. 44 1997 73 107
4. N.W. Barton, R.O. Brady, J.M. Dambrosia, A.M. Di Bisceglie, S.H. Doppelt, S.C. Hill, H.J. Mankin, G.J. Murray, R.I. Parker, and C.E. Argoff Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease N. Engl. J. Med. 324 1991 1464 1470
5. R.O. Brady, P.G. Pentchev, A.E. Gal, S.R. Hibbert, and A.S. Dekaban Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease N. Engl. J. Med. 291 1974 989 993
6. E. Beutler, G.L. Dale, D.E. Guinto, and W. Kuhl Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation Proc. Natl. Acad. Sci. USA 74 1977 4620 4623
7. N.J. Weinreb, J. Charrow, H.C. Andersson, P. Kaplan, E.H. Kolodny, P. Mistry, G. Pastores, B.E. Rosenbloom, C.R. Scott, R.S. Wappner, and A. Zimran Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry Am. J. Med. 113 2002 112 119
8. D.L. Stone, N. Tayebi, E. Orvisky, B. Stubblefield, V. Madike, and E. Sidransky Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease Hum. Mutat. 15 2000 181 188
9. R.A. Gravel, M.M. Kabak, R.L. Proia, K. Sandhoff, K. Suzuki, and K. Suzuki The GM2 gangliosidoses C.R. Scriver A.L. Beaudet D. Valle W.S. Sly B. Childs K.W. Kinzler B. Vogelstein The Metabolic and Molecular Basis of Inherited Disease vol. 3 2001 McGraw-Hill New York 3827 3876
10. M.T. Moran, J.P. Schofield, A.R. Hayman, G.P. Shi, E. Young, and T.M. Cox Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K Blood 96 2000 1969 1978
11. E. Orvisky, J.K. Park, M.E. LaMarca, E.I. Ginns, B.M. Martin, N. Tayebi, and E. Sidransky Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype Mol. Genet. Metab. 76 2002 262 270
12. E. Lloyd-Evans, D. Pelled, C. Riebeling, J. Bodennec, A. De-Morgan, H. Waller, R. Schiffmann, and A.H. Futerman Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms J. Biol. Chem. 2003
13. J. Bodennec, D. Pelled, C. Riebeling, S. Trajkovic, and A.H. Futerman Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide FASEB J. 16 2002 1814 1816
14. R. Myerowitz, D. Lawson, H. Mizukami, Y. Mi, C.J. Tifft, and R.L. Proia Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling Hum. Mol. Genet. 11 2002 1343 1350
15. V.E. Velculescu, L. Zhang, B. Vogelstein, and K.W. Kinzler Serial analysis of gene expression Science 270 1995 484 487
16. K. Yasojima, E.G. McGeer, and P.L. McGeer High stability of mRNAs postmortem and protocols for their assessment by RT-PCR Brain Res. Brain Res. Protoc. 8 2001 212 218
17. L.S. Finn, M. Zhang, S.H. Chen, and C.R. Scott Severe type II Gaucher disease with ichthyosis, arthrogryposis and neuronal apoptosis: molecular and pathological analyses Am. J. Med. Genet. 91 2000 222 226
18. E.H. Margulies, and J.W. Innis eSAGE: managing and analysing data generated with serial analysis of gene expression (SAGE) Bioinformatics 16 2000 650 651
19. E.H. Margulies, S.L. Kardia, and J.W. Innis A comparative molecular analysis of developing mouse forelimbs and hindlimbs using serial analysis of gene expression (SAGE) Genome Res. 11 2001 1686 1698
20. B. Shouse American Association for the Advancement of Science annual meeting. Human gene count on the rise Science 295 2002 1457
21. K. Sandhoff, T. Kolter, and K. Hartzer Sphingolipid Activator Protiens eighth ed. C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The Metabolic and Molecular Basis of Inherited Disease vol. III 2001 McGraw-Hill New York 3371 3388
22. J.M. George The synucleins Genome Biol. 3 2001 1 6
23. D.F. Clayton, and J.M. George The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease Trends Neurosci. 21 1998 249 254
24. W.S. Davidson, A. Jonas, D.F. Clayton, and J.M. George Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes J. Biol. Chem. 273 1998 9443 9449
25. E. Jo, J. McLaurin, C.M. Yip, P. St George-Hyslop, and P.E. Fraser alpha-Synuclein membrane interactions and lipid specificity J. Biol. Chem. 275 2000 34328 34334
26. F.H. Ueda, E. Masliah, Y. Xia, A. Iwa, M. Yoshimoto, D.A. Otero, J. Kondo, Y. Ihara, and T. Saitoh Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer Disease Proc. Natl. Acad. Sci. USA 90 1993 11282 11286
27. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe, and R.L. Nussbaum Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
28. M.G. Spillantini, R.A. Crowther, R. Jakes, M. Hasegawa, and M. Goedert alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies Proc. Natl. Acad. Sci. USA 95 1998 6469 6473
29. T. Jia, Y.E. Liu, J. Liu, and Y.E. Shi Stimulation of breast cancer invasion and metastasis by synuclein gamma Cancer Res. 59 1999 742 747
30. J.E. Galvin, K. Uryu, V.M. Lee, and J.Q. Trojanowskim Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein Proc. Natl. Acad. Sci. USA 96 1999 13450 13455
31. N. Tayebi, M. Callahan, V. Madike, B.K. Stubblefield, E. Orvisky, D. Krasnewich, J.J. Fillano, and E. Sidransky Gaucher disease and parkinsonism: a phenotypic and genotypic characterization Mol. Genet. Metab. 73 2001 313 321
32. M. Machaczka, M. Rucinska, A.B. Skotnicki, and W. Jurczak Parkinson's syndrome preceding clinical manifestation of Gaucher's disease Am. J. Hematol. 61 1999 216 217
33. N. Tayebi, J. Walker, B. Stubblefield, E. Orvisky, M.E. LaMarca, K. Wong, H. Rosenbaum, R. Schiffmann, B. Bembi, E. Sidransky, Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Molecular Genetics and Metabolism 80 (2003), on line
34. T. Suzuki, S. Hashimoto, N. Toyoda, S. Nagai, N. Yamazaki, H.Y. Dong, J. Sakai, T. Yamashita, T. Nukiwa, and K. Matsushima Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE Blood 96 2000 2584 2591
35. P. Pesheva, S. Urschel, K. Frei, and R. Probstmeier Murine microglial cells express functionally active galectin-3 in vitro J. Neurosci. Res. 51 1998 49 57
36. S. Hashimoto, T. Suzuki, H.Y. Dong, N. Yamazaki, and K. Matsushima Serial analysis of gene expression in human monocytes and macrophages Blood 94 1999 837 844
37. S. Haga, T. Aizawa, T. Ishii, and K. Ikeda Complement gene expression in mouse microglia and astrocytes in culture: comparisons with mouse peritoneal macrophages Neurosci. Lett. 216 1996 191 194
38. J. Van Beek, P. Chan, M. Bernaudin, E. Petit, E.T. MacKenzie, and M. Fontaine Glial responses, clusterin, and complement in permanent focal cerebral ischemia in the mouse Glia 31 2000 39 50
39. M. Ishizaka, Y. Ohe, T. Senbongi, K. Wakabayashi, and K. Ishikawa Inflammatory stimuli increase prostaglandin D synthase levels in cerebrospinal fluid of rats Neuroreport 12 2001 1161 1165
40. D. Chabas, S.E. Baranzini, D. Mitchell, C.C. Bernard, S.R. Rittling, D.T. Denhardt, R.A. Sobel, C. Lock, M. Karpuj, R. Pedotti, R. Heller, J.R. Oksenberg, and L. Steinman The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease Science 294 2001 1731 1735